Healthcare M&A in 2025 has remained resilient, even amid tighter capital markets and heightened regulatory scrutiny.

Across provider services, healthcare IT, revenue cycle management, and patient engagement platforms, buyers continue to pursue scale, operational leverage, and differentiated capabilities. Private equity sponsors are selectively exiting mature assets, strategic acquirers are filling product and distribution gaps, and transaction structures are increasingly shaped by valuation discipline and execution risk.

What hasn’t changed is how early these deals begin forming.

Long before a transaction is announced, employees inside healthcare organizations begin consuming discovery content tied to selling a business — including exit strategies, valuation frameworks, merger agreements, private equity deal structures, and topics most closely associated with sell-side advisory. These behavioral signals consistently emerge months before bankers are formally engaged or processes become visible to the market.

Fintent analyzes millions of anonymized employee research patterns to identify this early sell-side intent. In healthcare specifically, these signals surface well ahead of public disclosures, offering a measurable window into transaction readiness.

Across the 11 healthcare services acquisitions below, Fintent detected elevated M&A intent an average of ~13 months before deal announcements, reinforcing a consistent truth: healthcare transactions are rarely reactive — and almost never sudden.